isoxazoles has been researched along with Atherosclerosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bot, I; Kritikou, E; Kröner, MJ; Kuiper, J; Schaftenaar, FH; Swart, M; van der Heijden, T; van Puijvelde, GH; van Santbrink, PJ | 1 |
| Eggertsen, G; Gåfvels, M; Jiang, ZY; Kannisto, K; Ovchinnikova, O; Parini, P; Paulsson-Berne, G; Slätis, K | 1 |
| Barter, PJ; Beattie, DT; Bursill, CA; Castro, ML; Heather, AK; Nakhla, S; Rye, KA; van der Vorst, E | 1 |
| Baldelli, F; Cipriani, S; D'Amore, C; Fiorucci, S; Francisci, D; Mencarelli, A; Renga, B; Schiaroli, E | 1 |
| Boettcher, A; Burnet, M; Deuschle, U; Hahn, U; Hambruch, E; Kinzel, O; Kremoser, C; Krol, HD; Levi, M; Matysik, S; Miyazaki, M; Miyazaki-Anzai, S; Perović-Ottstadt, S; Schlüter, T; Schmitz, G | 1 |
| Bruno, A; Di Vito, C; Emanuele, E; Minoretti, P | 1 |
6 other study(ies) available for isoxazoles and Atherosclerosis
| Article | Year |
|---|---|
Inhibition of lysophosphatidic acid receptors 1 and 3 attenuates atherosclerosis development in LDL-receptor deficient mice.
Topics: Animals; Atherosclerosis; Cholesterol, LDL; Disease Models, Animal; Endocytosis; Humans; Isoxazoles; Lysophospholipids; Mice; Propionates; Receptors, LDL; Receptors, Lysophosphatidic Acid; Signal Transduction | 2016 |
Abolished synthesis of cholic acid reduces atherosclerotic development in apolipoprotein E knockout mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Bile; Cholesterol; Cholic Acids; Gene Knockout Techniques; Intestinal Absorption; Isoxazoles; Liver; Mice; Micelles; Receptors, Cytoplasmic and Nuclear | 2010 |
High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo.
Topics: Animals; Apolipoprotein A-I; Apolipoproteins E; Atherosclerosis; Cells, Cultured; Chemokine CCL2; Chemokine CCL5; Chemokine CX3CL1; Chemokines; Chemotaxis, Leukocyte; Disease Models, Animal; Down-Regulation; Endothelial Cells; Humans; I-kappa B Proteins; Injections, Intravenous; Isoxazoles; Lipoproteins, HDL; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; NF-KappaB Inhibitor alpha; Phosphorylation; PPAR gamma; Receptors, CCR2; Receptors, Chemokine; Receptors, Interleukin-8A; RNA, Messenger; Sulfones; Transcription Factor RelA | 2010 |
The HIV matrix protein p17 subverts nuclear receptors expression and induces a STAT1-dependent proinflammatory phenotype in monocytes.
Topics: Atherosclerosis; Cell Line; Cell Separation; gag Gene Products, Human Immunodeficiency Virus; Gene Expression Regulation; GTP-Binding Proteins; HIV Antigens; HIV Infections; HIV-1; Humans; Inflammation; Isoxazoles; Janus Kinases; Lipid Metabolism; Lipopolysaccharide Receptors; Macrophages; Monocytes; Neoplasm Proteins; Neutralization Tests; Phenotype; Phosphorylation; PPAR gamma; Receptors for Activated C Kinase; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Signal Transduction; STAT1 Transcription Factor; Thiazolidinediones; Vaccination; Vidarabine | 2012 |
Synthetic farnesoid X receptor agonists induce high-density lipoprotein-mediated transhepatic cholesterol efflux in mice and monkeys and prevent atherosclerosis in cholesteryl ester transfer protein transgenic low-density lipoprotein receptor (-/-) mice.
Topics: Animals; Anticholesteremic Agents; Aorta; Atherosclerosis; Benzoates; Biological Transport; Cholesterol; Cholesterol Ester Transfer Proteins; Diet, High-Fat; Disease Models, Animal; Feces; Female; Humans; Isoxazoles; Lipoproteins, HDL; Liver; Macaca fascicularis; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molecular Structure; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, LDL; Species Specificity; Structure-Activity Relationship | 2012 |
Leflunomide as an antiatherogenic drug.
Topics: Antigen-Presenting Cells; Antirheumatic Agents; Atherosclerosis; Chemotaxis; Dendritic Cells; Humans; Isoxazoles; Leflunomide; Leukocytes, Mononuclear; Models, Cardiovascular; NF-kappa B; Signal Transduction | 2007 |